<DOC>
	<DOCNO>NCT01584739</DOCNO>
	<brief_summary>This study investigate safety , tolerability , pharmacokinetics pharmacodynamics multiple ascend inhaled dos AZD8683 Healthy volunteer repeat inhalation one dose level AZD8683 patient chronic obstructive pulmonary disease give daily .</brief_summary>
	<brief_title>AZD8683 Multiple Dose Study Healthy Volunteers Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description>A Phase I , Single Centre , Double-Blind , Randomised , Placebo- control , Parallel-group Study Assess Safety , Tolerability , Pharmacokinetics Pharmacodynamics Multiple Ascending Inhaled Doses AZD8683 Healthy Volunteers COPD patient</detailed_description>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Healthy male volunteer healthy female volunteer nonchild bear potential , age 18 45 year inclusive suitable vein cannulation repeat venepuncture Healthy volunteer Have body mass index ( BMI ) 19 30 kg/m2 weigh least 50 kg 100 kg inclusive Healthy volunteer COPD patient Be able inhale Turbuhaler® inhaler accord give instruction well able perform spirometry Healthy volunteer COPD patient . Male COPD patient female COPD patient nonchildbearing potential ( post menopausal surgically sterilise ) age ≥40 year Visit 1 COPD patient Female healthy volunteer female patient ≤60 year must negative pregnancy test screen admission unit Healthy volunteer COPD patient Prolonged QTcF &gt; 450 m shorten QTcF &lt; 340 m family history long QT syndrome Healthy volunteer COPD patient History severe allergy/hypersensitivity ongoing allergy/hypersensitivity , judge investigator history hypersensitivity drug similar chemical structure class AZD8683 excipients : Healthy volunteer COPD patient History presence gastrointestinal , pulmonary , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Healthy volunteer COPD patient Any clinically significant illness ( COPD ) , medical/surgical procedure trauma within 4 week first administration investigational product COPD patient Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product Healthy volunteer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>COPD ( chronic obstructive pulmonary disease )</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>inhale</keyword>
</DOC>